Bafna Pharmaceuticals widens net loss to Rs 2.08 crore in Q4

01 Jun 2012 Evaluate

Bafna Pharmaceuticals has reported a widening of its standalone net loss to Rs 2.08 crore for the quarter ended March 31, 2012 as compared to a net loss of Rs 0.85 crore over the same period previous fiscal. However, the net sales of the company increased by 10.57% to Rs 32.73 crore in the quarter under review from Rs 29.60 crore in same period year ago.

For the full year, the company’s net profit declined by 38.05% at Rs 20.74 crore against Rs 33.48 crore for the previous fiscal however, net sales of the company rose 19.43% to Rs 120.98 crore for FY12 from Rs 101.30 crore for FY11.

Bafna Pharma Share Price

74.90 1.90 (2.60%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...